These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26213097)

  • 1. IL-2/IL-2 antibody immune complex regulates HSV-induced inflammation through induction of IL-2 receptor alpha, beta, and gamma in a mouse model.
    Choi JY; Choi B; Shim JA; Lee ES; Kim DY; Bang D; Sohn S
    Immunobiology; 2015 Dec; 220(12):1381-92. PubMed ID: 26213097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potency of Poly I:C in HSV-induced inflammation through up-regulation of IL-15 receptor alpha.
    Choi J; Lee ES; Choi B; Sohn S
    Immunobiology; 2013 Sep; 218(9):1119-30. PubMed ID: 23618691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease.
    Sugi-Ikai N; Nakazawa M; Nakamura S; Ohno S; Minami M
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):996-1004. PubMed ID: 9579479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells.
    Zambello R; Trentin L; Cerutti A; Enthammer C; Milani A; Franceschi T; Messina C; Cetto GL; Agostini C; Semenzato G
    Cancer; 1994 Nov; 74(9):2562-9. PubMed ID: 7522954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4(+) CD25(+) regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model.
    Shim J; Lee ES; Park S; Bang D; Sohn S
    Cytotherapy; 2011 Aug; 13(7):835-47. PubMed ID: 21506890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and role of interleukin-2 receptor beta chain on CD4-CD8- T cell receptor alpha beta+ cells [corrected].
    Takeuchi Y; Tanaka T; Hamamura K; Sugimoto T; Miyasaka M; Yagita H; Okumura K
    Eur J Immunol; 1992 Nov; 22(11):2929-35. PubMed ID: 1425918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cells dominate a Th-1 polarized response in Behçet's disease patients with uveitis.
    Kucuksezer UC; Aktas-Cetin E; Bilgic-Gazioglu S; Tugal-Tutkun I; Gül A; Deniz G
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S24-9. PubMed ID: 25937098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
    Evereklioglu C; Er H; Türköz Y; Cekmen M
    Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2R.
    Voss SD; Sondel PM; Robb RJ
    J Exp Med; 1992 Aug; 176(2):531-41. PubMed ID: 1500859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of CCR1 and therapeutic effects of anti-CCL3 antibody in herpes simplex virus-induced Behçet's disease mouse model.
    Sayeed HM; Lee ES; Byun HO; Sohn S
    Immunology; 2019 Nov; 158(3):206-218. PubMed ID: 31393598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.
    Bamford RN; Grant AJ; Burton JD; Peters C; Kurys G; Goldman CK; Brennan J; Roessler E; Waldmann TA
    Proc Natl Acad Sci U S A; 1994 May; 91(11):4940-4. PubMed ID: 8197161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular cytokine patterns in Behçet's disease in comparison to ankylosing spondylitis--influence of treatment with interferon-alpha2a.
    Amberger M; Groll S; Günaydin I; Deuter C; Vonthein R; Kötter I
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S52-7. PubMed ID: 17949552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequencies of IL-15Rα+ cells in patients with Behçet's disease and the effects of overexpressing IL-15Rα+ on disease symptoms in mice.
    Islam SMS; Choi B; Choi J; Lee ES; Sohn S
    Cytokine; 2018 Oct; 110():257-266. PubMed ID: 29396044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential expression of IL-2 receptor subunits on memory populations within CD4+ and CD8+ T cells.
    Taga K; Kasahara Y; Yachie A; Miyawaki T; Taniguchi N
    Immunology; 1991 Jan; 72(1):15-9. PubMed ID: 1900055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behçet's disease patients present high levels of deglycosylated anti-lipoteichoic acid IgG and high IL-8 production after lipoteichoic acid stimulation.
    Cuchacovich M; Merino G; Yamamoto JH; Villarroel F; Saavedra T; Jofre S; Gatica H; Velasquez V; Pizzo SV; Gonzalez-Gronow M
    Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S27-34. PubMed ID: 16273761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the ovine interleukin-2 receptor-alpha chain: differential induction on precultured alpha beta and gamma delta T cells.
    Verhagen AM; Brandon MR; Nash AD
    Immunology; 1993 Jul; 79(3):471-8. PubMed ID: 8406574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-37 expression is decreased in Behçet's disease and is associated with inflammation.
    Bouali E; Kaabachi W; Hamzaoui A; Hamzaoui K
    Immunol Lett; 2015 Oct; 167(2):87-94. PubMed ID: 26253248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of IL-15 with the shared IL-2 receptor beta and gamma c subunits. The IL-15/beta/gamma c receptor-ligand complex is less stable than the IL-2/beta/gamma c receptor-ligand complex.
    de Jong JL; Farner NL; Widmer MB; Giri JG; Sondel PM
    J Immunol; 1996 Feb; 156(4):1339-48. PubMed ID: 8568232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2, interleukin-6 and T regulatory cells in peripheral blood of patients with Behçet's disease and recurrent aphthous ulcerations.
    Pekiner FN; Aytugar E; Demirel GY; Borahan MO
    J Oral Pathol Med; 2012 Jan; 41(1):73-9. PubMed ID: 21736625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The levels of plasma interleukin-2 and soluble interleukin-2R in Behçet's disease: a marker of disease activity.
    Alpsoy E; Cayirli C; Er H; Yilmaz E
    J Dermatol; 1998 Aug; 25(8):513-6. PubMed ID: 9769596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.